Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program
Journal of Oncology Practice · 2018-06 · 14 (6) · e324-e334
DOI: 10.1200/jop.17.00039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncology Practice, 2018-06. Verfasst von Benyam Muluneh und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of North Carolina (UNC) at Chapel Hill; UNC Medical Center, Chapel Hill, NC; and Ralph H. Johnson Veterans Affairs Medical Center, Charles…. Hauptthemen laut MEDLINE: Delivery of Health Care, Integrated, Medication Adherence, Medication Therapy Management, Outcome Assessment, Health Care. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 9 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
To address the growing use of oral anticancer therapy, an integrated, closed-loop, pharmacist-led oral chemotherapy management program was created within an academic medical center.
Methods
An integrated, closed-loop, pharmacy-led oral chemotherapy management program was established. From September 2014 until June 2015, demographic information, rates of adherence, patient understanding of treatment, pharmacist interventions, patient and provider satisfaction, and molecular response rates in patients with chronic myeloid leukemia (CML) were collected.
Results
After full implementation, 107 patients were enrolled in our oral chemotherapy management program from September 2014 until June 2015. All patients were educated before starting oral chemotherapy, and using pre- and postassessment tests, comprehension of oral chemotherapy treatment increased from 43% to 95%. Patient-reported adherence was 86% and 94.7% for the GI/breast and malignant hematology patient populations, respectively, and these were validated with medication possession ratio, revealing adherence rates of 85% and 93.9% for the GI/breast and malignant hematology patient populations, respectively. A total of 350 encounters with a clinical pharmacist and 318 adverse effects were reported, which led to 235 interventions. This program led to a higher major molecular response rate (83%) in our CML population compared with published clinical trials (average major molecular response rates, 40% and 60% with 1- and 2-year follow-up, respectively).
Conclusion
An innovative model was developed and resulted in improved patient knowledge regarding oral chemotherapy, improved adherence rates that exceeded nationally established thresholds, and superior major molecular response outcomes for patients with CML compared with published literature. As a result, this model has produced the gold standard in managing patients receiving oral chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of North Carolina (UNC) at Chapel Hill; UNC Medical Center, Chapel Hill, NC; and Ralph H. Johnson Veterans Affairs Medical Center, Charleston, SC.
Zitieren
APA
Muluneh, B., Schneider, M., Faso, A., Amerine, L., Daniels, R., Crisp, B., Valgus, J., & Savage, S. (2018). Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program. Journal of Oncology Practice, 14(6), e324-e334. https://doi.org/10.1200/jop.17.00039
Vancouver
Muluneh B, Schneider M, Faso A, Amerine L, Daniels R, Crisp B, et al. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program. Journal of Oncology Practice. 2018;14(6):e324-e334. doi:10.1200/jop.17.00039
BibTeX
@article{Muluneh2018,
author = {Muluneh, Benyam and Schneider, Molly and Faso, Aimee and Amerine, Lindsey and Daniels, Rowell and Crisp, Brett and Valgus, John and Savage, Scott},
title = {Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program},
journal = {Journal of Oncology Practice},
year = {2018},
volume = {14},
number = {6},
pages = {e324--e334},
doi = {10.1200/jop.17.00039}
}
EUVIMED